中文 | English
Return
Total: 50 , 1/5
Show Home Prev Next End page: GO
Author:(Shengnan GAO)

1.Cost-utility analysis of anlotinib combined with penpulimab in first-line treatment of unresectable hepatocellular carcinoma

Wenying YAN ; Na YANG ; Ranran ZHANG ; Xinyue TAO ; Shengnan GAO ; Guoqiang LIU

China Pharmacy 2026;37(3):344-349

2.Cost-utility analysis of amivantamab combined with lazertinib in the first-line treatment of EGFR-mutated advanced NSCLC

Ran LIU ; Shengnan GAO ; Yuxi ZHANG ; Ranran ZHANG ; Congxin LI ; Guoqiang LIU

China Pharmacy 2026;37(5):633-638

3.Pharmacoeconomic evaluation of culmerciclib combined with fulvestrant in the second-line treatment of HR+/HER2− locally advanced or metastatic breast cancer

Ran LIU ; Shengnan GAO ; Congxin LI ; Yuxi ZHANG ; Ranran ZHANG ; Yue WANG ; Ziyi LIU ; Guoqiang LIU

China Pharmacy 2026;37(8):1033-1038

4.Cost-effectiveness analysis of sacituzumab tirumotecan versus single-agent chemotherapy in second-line and later-line treatment for metastatic triple-negative breast cancer

Ranran ZHANG ; Yuxi ZHANG ; Shengnan GAO ; Bing FENG ; Ning GAO ; Guoqiang LIU

China Pharmacy 2025;36(16):2024-2029

5.Differences in cytokines expression between mild and severe infant cases infected with respiratory syncytial virus

Guangyu XUE ; Yuting HU ; Kexin ZONG ; Qin LUO ; Shengnan YANG ; Miao FENG ; Xiaoyu YI ; Zhiqiang XIA ; Chen GAO ; Haijun DU ; Ying LI ; Ying CHEN ; Feng HE ; Yajuan WANG ; Yingli QU ; Jin CAO ; Wenyan TIAN ; Qinqin SONG ; Hailan YAO ; Jun HAN

Chinese Journal of Experimental and Clinical Virology 2025;39(3):370-377

6.Exploration on Correlation Between Toxins Damaging Liver Collateral and Type 2 Diabetes Mellitus Based on Five-Circuit and Six-Qi Theory

Yu WANG ; Xue WANG ; Ming YANG ; Shengnan GAO ; Wenqi JIN ; Chunli PIAO

Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(6):1327-1333

7.Construction and validation of a risk prediction model for acute myocardial infarction complicated by malignant ventricular arrhythmias

Dongli SONG ; Shengnan LIU ; Shuo WU ; Jie GAO ; Xiao ZHANG ; Weikai CUI ; Yifan WANG ; Jiali WANG ; Yuguo CHEN

Chinese Journal of Emergency Medicine 2025;34(7):923-931

8.Hemolytic phenotype analysis of Staphylococcus aureus clinical isolates

Ju Gao ; Shengnan Weng ; Guiyun Leng ; Xin Li ; Jie Yao ; Qiang Zhou ; Wei Tang

Acta Universitatis Medicinalis Anhui 2025;60(7):1312-1319

9.Cost-utility analysis of benmelstobart plus anlotinib and chemotherapy as first-line treatment for extensive-stage small cell lung cancer

Bing FENG ; Ning GAO ; Shengnan GAO ; Yuxi ZHANG ; Ranran ZHANG ; Guoqiang LIU

China Pharmacy 2025;36(5):579-583

10.Seasonal distribution characteristics, source analysis and health risk assessment of polycyclic aromatic hydrocarbons in PM2.5 in Lianyungang City in 2019-2023

Shengnan GAO ; Jinkun LI ; Li CHEN ; Zhengdong XYU ; Hongru ZHU ; Jian WANG ; Zhiyang YAO

Journal of Public Health and Preventive Medicine 2025;36(1):65-69

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 50 , 1/5 Show Home Prev Next End page: GO